HedgeChatter

  • Home /
  • Tag Archives

CRIS

Curis, Inc. Discusses Q3 2013 Results (Webcast)

[at Seeking Alpha] – The following audio is from a conference call that will begin on February 20, 2014 at 09:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is […]

February 20, 2014 Bystocknews , Comments Off on Curis, Inc. Discusses Q3 2013 Results (Webcast) read more

7:16 am Curis beats by $0.02, misses on revs

moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on 7:16 am Curis beats by $0.02, misses on revs read more

Curis Reports Fourth Quarter and Year-End 2013 Financial Results

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today reported its financial results for the fourth quarter … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on Curis Reports Fourth Quarter and Year-End 2013 Financial Results read more

Curis to Release Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call on February 20, 2014

[GlobeNewswire] – LEXINGTON, Mass. — Curis, Inc. , an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced that the Company will release its fourth quarter … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on Curis to Release Fourth Quarter and Year End 2013 Financial Results and Hold Conference Call on February 20, 2014 read more

Curis to Present at the BioCentury Future Leaders in the Biotech Industry Conference

[at noodls] – LEXINGTON, Mass., March 29, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

March 29, 2013 Bystocknews , Comments Off on Curis to Present at the BioCentury Future Leaders in the Biotech Industry Conference read more

Curis to Present at the Cowen and Company 33rd Annual Health Care Conference

[at noodls] – LEXINGTON, Mass., Feb. 25, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today announced … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 25, 2013 Bystocknews , Comments Off on Curis to Present at the Cowen and Company 33rd Annual Health Care Conference read more

Curis Reports Fourth Quarter and Year-End 2012 Financial Results

[at noodls] – Conference Call to Discuss Results and Provide 2013 Outlook Today at 9:00 a.m. EST LEXINGTON, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), an oncology-focused company seeking to … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 20, 2013 Bystocknews , Comments Off on Curis Reports Fourth Quarter and Year-End 2012 Financial Results read more

Curis to Release Fourth Quarter and Year End 2012 Financial Results and Hold Conference Call on February 20, 2013

[at noodls] – LEXINGTON, Mass., Feb. 13, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the … moreView todays social media effects on CRISView the latest stocks trending across Twitter. Click to view dashboardSee who Curis is hiring next, click here to view […]

February 13, 2013 Bystocknews , Comments Off on Curis to Release Fourth Quarter and Year End 2012 Financial Results and Hold Conference Call on February 20, 2013 read more